Antibody response to Streptokinase

AuthorA Afsharien
AuthorE Holmeen
AuthorS Hillisen
Issued Date2000-12-31en
AbstractAbstract Background: Streptokinase is administered during acute myocardial infarction (AMI). It is prepared from beta haemolytic streptococci and in some cases pre-existing antibodies may compromise the use of streptokinase. Objective: To study levels of anti-streptokinase antibodies in AMI patients during thrombolytic therapy. Methods: Specific IgG, IgA, IgM and anti-streptokinase antibodies (ELISA) were studied in 246 cases. Pre and post-therapy levels of these antibodies were examined in 10 cases given streptokinase for AMI. Findings: Neutralizing anti-streptokinase were detectable in 61.7% of the controls which 0.43% of them had levels above the normal range. Neutralizing anti-streptokinase antibodies showed a positive correlation with the level of IgG anti-streptokinase antibodies (r=+0.55, Pen
DOIhttps://doi.org/en
KeywordKeywords: Streptokinaseen
KeywordAcute myocardial infarction (AMI)en
PublisherBrieflandsen
TitleAntibody response to Streptokinaseen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
article-1-643-en.pdf.pdf
Size:
961.16 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF